(Allergan plc)

	AGN latest price $195.5711 (-0.43%) ($191.8167 - $197.6327) on Thu. Apr. 24, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.21% (three month average)
RSI	46
Latest Price	$195.5711(-0.43%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.3% a day on average for past five trading days.
Weekly Trend	AGN advances 1.1% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    XBI(46%)    QQQ(43%)    SPY(43%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -1.105% in a week (0% probabilities).   TLT(-18%)    SHY(-8%)    IGOV(-6%)    GLD(-6%)    TIP(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.105% (StdDev 2.21%)
Hourly BBV	0 ()
Intraday Trend	-0.7%

5 Day Moving Average	$195.37(0.1%)
10 Day Moving Average	$190.92(2.44%)
20 Day Moving Average	$192.99(1.34%)
To recent high	-7.3%
To recent low	7.3%
Market Cap	$64.48b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed